fda glp-1 compounding enforcement october 2025 is short-sighted on GLP-1s Beyond the Headlines: FDA Warning

SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, is announcing the availability of its ready-to-use (RTU) cartridges for clinical and commercial filling.

Mat naturally contains a wide range of polyphenols, methylxanthines, and chlorogenic acid, which together are responsible for its many health benefits.*

In that vein, and converging with many news and policy events, Im trend-weaving the latest insights into that most consumer-facing of the social determinants of health: food, and in particular, health consumers viewing and adopting food as part of their health and well-being moves

Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control

Are GLP-1 medications safe whilst breastfeeding

Identification of genetic variants associated with the efficacy and side effects of GLP1 medications could underpin development of precision medicine approaches in the treatment of obesity.